Search - tctmd.com

Displaying 61 - 80 of 83

Sort: Relevancy | Date

News Industry News

Medtronic Receives FDA Approval for IN.PACT Admiral DCB 150 mm Lengths

July 13, 2016

News Industry News

Essential Medical Inc. Announces FDA Approval to Begin a U.S. Clinical Trial for the MANTA™ Large Bore Vascular Closure Device

July 08, 2016

News Daily News

Drug-Coated Balloons Beat Angioplasty for SFA In-Stent Restenosis, but Long-Term Solutions Needed

Caitlin E. Cox

July 07, 2016

News Industry News

CARDIONOVUM Announces Enrollment Completion of RAPID Trial

June 06, 2016

News Industry News

Shockwave Medical Announces Positive Study Results of Novel Lithoplasty System to Treat Peripheral Artery Disease

April 27, 2016

News Industry News

CARDIONOVUM Announces Enrollment of First Patient in MAGNIFICENT Trial

April 07, 2016

News Daily News

FDA Issues Class I Recall for Intra-Aortic Balloon Catheter and Percutaneous Insertion Kits

Michael O'Riordan

March 18, 2016

News Industry News

Boston Scientific Receives CE Mark For Eluvia™ Drug-Eluting Vascular Stent and Announces Initiation of New Clinical Trial

February 21, 2016

News Daily News

FDA: Global Recall of Cook Medical Central Venous Catheters and Pressure Monitoring Sets, Trays

L.A. McKeown

February 10, 2016

News Conference News ISET 2016

Drug-Coated Balloon Angioplasty Superior for In-Stent Restenosis of SFA, but Results Leave Much To Be Desired

Michael O'Riordan

February 10, 2016

News Industry News

First Patients Enrolled in the Gore RELINE MAX Clinical Study

December 15, 2015

News Daily News

Meta-Analysis Boosts Case for Increased Use of Radial Access

November 29, 2015

News Daily News

Campeau Paradox: Is Femoral Proficiency Lost When Radial Access Thrives?

L.A. McKeown

November 24, 2015

News Conference News TCT 2015

IN.PACT SFA: Benefits of DCB Persist at 2 Years

October 14, 2015

News Industry News

Drug-Coated Balloon Shown To Be Superior To Conventional Angioplasty In Treating Superficial Femoral Artery Disease After Two Years

October 14, 2015

News Features TCT 2014

Thoughtful Insights at TCT: Tackling Resistant Hypertension, Long SFA Lesions, and Complex Carotid Disease

Todd Neale

October 31, 2014

News Daily News

Drug-Eluting Balloon Provides Strong Primary Patency in SFA at 1 Year

April 14, 2014

News Daily News

First-Generation Bioresorbable Stent Performs Well in SFA Lesions

Jason Kahn

February 20, 2014

News Daily News

Bioresorbable Scaffold Designed for PAD Yields Good Early Results

January 22, 2014

News Daily News

Patency Higher, Reintervention Lower with Stenting vs. Surgery in PAD

August 12, 2013

Advertisement

Medtronic Receives FDA Approval for IN.PACT Admiral DCB 150 mm Lengths

Essential Medical Inc. Announces FDA Approval to Begin a U.S. Clinical Trial for the MANTA™ Large Bore Vascular Closure Device

Drug-Coated Balloons Beat Angioplasty for SFA In-Stent Restenosis, but Long-Term Solutions Needed

CARDIONOVUM Announces Enrollment Completion of RAPID Trial

Shockwave Medical Announces Positive Study Results of Novel Lithoplasty System to Treat Peripheral Artery Disease

CARDIONOVUM Announces Enrollment of First Patient in MAGNIFICENT Trial

FDA Issues Class I Recall for Intra-Aortic Balloon Catheter and Percutaneous Insertion Kits

Boston Scientific Receives CE Mark For Eluvia™ Drug-Eluting Vascular Stent and Announces Initiation of New Clinical Trial

FDA: Global Recall of Cook Medical Central Venous Catheters and Pressure Monitoring Sets, Trays

Drug-Coated Balloon Angioplasty Superior for In-Stent Restenosis of SFA, but Results Leave Much To Be Desired

First Patients Enrolled in the Gore RELINE MAX Clinical Study

Meta-Analysis Boosts Case for Increased Use of Radial Access

Campeau Paradox: Is Femoral Proficiency Lost When Radial Access Thrives?

IN.PACT SFA: Benefits of DCB Persist at 2 Years

Drug-Coated Balloon Shown To Be Superior To Conventional Angioplasty In Treating Superficial Femoral Artery Disease After Two Years

Thoughtful Insights at TCT: Tackling Resistant Hypertension, Long SFA Lesions, and Complex Carotid Disease

Drug-Eluting Balloon Provides Strong Primary Patency in SFA at 1 Year

First-Generation Bioresorbable Stent Performs Well in SFA Lesions

Bioresorbable Scaffold Designed for PAD Yields Good Early Results

Patency Higher, Reintervention Lower with Stenting vs. Surgery in PAD

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content